Shares of AXT Inc. cratered 10.1% to $60.18 Thursday after a bearish analyst report argued the specialty wafer maker's explosive profit margins are built on fragile ground. The downgrade landed on a rough day for chips broadly — SOXX fell about 2.6% — but AXT's selloff was four times worse, signaling this is a company-specific reckoning, not just sector noise.
A Record Quarter That May Already Be the Peak
AXT posted record Q2 revenue of $47.6 million, up 77% sequentially and 164% year-over-year, while non-GAAP gross margin surged to 45.0% from 29.9% in Q1. The analyst's core argument: that jump was powered by a one-time convergence of tight supply, favorable product mix, and high factory utilization — conditions that are already loosening. The report warns that "contractual caps and easing shortages signal imminent margin reversion." If gross margin (the share of revenue left after manufacturing costs) slides back toward 30%, earnings evaporate.
The 6-Inch Wafer Problem Gives Rivals an Opening
The industry is shifting to larger 6-inch indium phosphide wafers, and the analyst argues AXT lags competitors in scaling yields and consistency on the new format.
Management acknowledges that further margin improvement partly depends on successfully migrating to those larger-diameter substrates. Falling behind here could erode AXT's pricing power precisely as supply catches up to AI-driven demand.
A Valuation Untethered From Fundamentals
AXT commands a $7.37 billion market cap on just $95.89 million in trailing twelve-month revenue.
Its price-to-sales ratio — how much investors pay per dollar of revenue — has climbed to roughly 37.6x , dwarfing the semiconductor sector median of around 3x. The bearish base-case fair value is pegged at $45, well below current levels. Even bulls concede risk: basic shares outstanding rose 40% year-over-year after a $632.5 million capital raise, structurally diluting earnings per share.
A $100 Million Backlog Cuts Both Ways
AXT's backlog exceeds $100 million and extends into 2027, with management saying it "could be significantly larger if the company accepted all available orders." That sounds bullish — until you realize the stock already prices in flawless execution. Insiders have sold $78.8 million in shares over the past year with no buying activity reported , a pattern that suggests those closest to the business see the current price as generous. For shareholders, the question is whether AI demand can grow fast enough to justify a valuation that already assumes perfection.